Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single Group, Open, Extension Study of Phase III Clinical Trial to Compare the Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines

NCT06124794 is registered in ClinicalTrials.gov with Protox Inc. as lead sponsor.

NCT NCT06124794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06124794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single Group, Open, Extension Study of Phase III Clinical Trial to Compare the Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines
Lead sponsor
Protox Inc.
Phase
Phase 3
Overall status
Completed
Start date
December 18, 2023
Completion date
June 14, 2024
Enrollment
155 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

glabellar frown lines